Tumour devascularisation as a potential immunotherapeutic strategy
Status PubMed-not-MEDLINE Jazyk angličtina Země Spojené státy americké Médium electronic-ecollection
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
30546967
PubMed Central
PMC6287775
DOI
10.1080/2162402x.2018.1526614
PII: 1526614
Knihovny.cz E-zdroje
- Klíčová slova
- Immunotherapy, cancer, devascularisation, ischaemia, tumour ligation,
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Complete tumour devascularisation (CTD) is a surgical technique which entails the complete disruption by ligation or cutting of afferent and efferent tumour vasculature which remains in situ. In some animal models, CTD induces immune responses that lead to regression of distant metastases and protective immunity.
EUC Premium s r o Brno Czech Republic
Institute of Molecular Genetics of the Czech Academy of Sciences Prague Czech Republic
Zobrazit více v PubMed
Lewis MR, Aptekman PM.. Antigenicity of sarcomata undergoing atrophy in rats. J Immunol. 1951. September;67(3):193–195. PMID: 14888881. PubMed
Fardon JC, Prince JE. An attempt to induce resistance in an inbred strain of mice by ligation of a homologous tumor. Cancer Res. 1953. January;13(1):9–13. PMID: 13032942. PubMed
Foley EJ. Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin. Cancer Res. 1953;13:835–837. PMID: 13116120. PubMed
Prehn RT, Main JM. Immunity to methylcholanthrene-induced sarcomas. J Natl Cancer Inst. 1957. June;18(6):769–778. PMID: 13502695. PubMed
Gorelik E. Concomitant tumor immunity and the resistance to a second tumor challenge. Adv Cancer Res. 1983;39:71–120. PMID: 6194674. PubMed
Fortýn K, Hradecký J, Pazdera J, Klaudy J, Hruban V, Dvorák P, Matousek J, Tichý J, Kolín V. Small and large intestine devascularization devitalization and potentials in the therapeutic use of this operative method. Z Exp Chir Transplant Kunstliche Organe. 1985;18(1):42–50. PMID: 2986369. PubMed
Fortyn K, Hruban V, Horák V. Treatment of malignant melanoma. Br J Surg. 1994;81(1):146–147. PMID:8155151. PubMed
Horák V, Fortyn K, Hruban V, Klaudy J. Hereditary melanoblastoma in miniature pigs and its successful therapy by devitalization technique. Cell Mol Biol (Noisy-Le-Grand). 1999;45(7):1119–1129. PMID: 10644016. PubMed
Fišer B. Letter of health secretary, ministry of health of the czech republic, to president of czech association of patients Report of preliminary results of clinical trials; 2002, ref. 3924/02. doi:10.1044/1059-0889(2002/er01) DOI
Lewis MR, Maxwell DB, Aptekman PM, Demchur P. Atrophy of sarcoma in rats followed by tumor immunity; a surgical method for development of tumor immunity in rats. Surgery. 1951. October;30(4):689–694. PMID:14893047. PubMed
Lewis MR, Aptekman PM. Atrophy of tumors caused by strangulation and accompanied by development of tumor immunity in rats. Cancer. 1952. March 5;(2):411–413. PMID: 14905430 doi:10.1002/1097-0142(195203)5:2<411::AID-CNCR2820050233>3.0.CO;2-R. PubMed DOI
Baldwin RW. Immunity to methylcholanthrene-induced tumours in inbred rats following atrophy and regression of the implanted tumours. Br J Cancer. 1955. December 9;(4):652–657. PMID: 13304228; PubMed Central PMCID: PMC2073778 doi:10.1038/bjc.1955.70. PubMed DOI PMC
Allen FM, Kaplan MM, Meranze DR, Gradess M. Treatment of spontaneous tumours by temporary local ligation. A comparative study in dogs. Bull World Health Organ. 1960;23:727–737. PMID: 13682514; PubMed Central PMCID: PMC2555381. PubMed PMC
Neel HB 3rd, Ritts RE Jr. Immunotherapeutic effect of tumor necrosis after cryosurgery, electrocoagulation, and ligation. J Surg Oncol. 1979;11(1):45–52. PMID: 431082. PubMed
Mohr SJ, Whitesel JA. Spontaneous regression of renal cell carcinoma metastases after preoperative embolization of primary tumor and subsequent nephrectomy. Urology. 1979. July;14(1):5–8. PMID: 452221. PubMed
Khafagy M, Wanebo HJ, Alfieri A, Hahn EW. Effect of different cancer treatment methods on immunity to an antigenic transplantable murine fibrosarcoma (Meth A). AJR Am J Roentgenol. 1977. June; 128(6):1027–1029. PMID: 414534 doi:10.2214/ajr.128.6.1027. PubMed DOI
Neel HB 3rd, Ketcham AS, Hammond WG. Experimental evaluation of in situ oncocide for primary tumor therapy: comparison of tumor-specific immunity after complete excision, cryonecrosis and ligation. Laryngoscope. 1973. March;83(3):376–387. PMID: 4690029 doi:10.1288/00005537-197303000-00009. PubMed DOI
Kamijo A, Koshino T, Uesugi M, Nitto H, Saito T. Inhibition of lung metastasis of osteosarcoma cell line POS-1 transplanted into mice by thigh ligation. Cancer Lett. 2002. December 15;188(1–2):213–219. PMID: 12406567. PubMed
Kalina V, Kopsky DJ. Autologous tumor immunizing devascularization in cancer therapy. Med Hypotheses. 2016. April; 89:72–78. PMID: 26968914 doi:10.1016/j.mehy.2016.02.004. PubMed DOI
Vašek P, Krajnik J, Kopsky DJ, Kalina V, Frydrych M. Autologous tumor immunizing devascularization of an invasive colorectal cancer: A case report and literature review. Mol Clin Oncol. 2016. November 5;5:521–526. PMID: 27882237 PMCID: PMC5103851. doi:10.3892/mco.2016.1033. PubMed DOI PMC
Pokorná E, Hradecký J, Morávková A, Burda P, Kotrnoch J, Klaudy J, Faldyna M, Sinkora J, Halouzka R, Jelínek F, et al. Tumour ligation (devitalisation) of mammary gland tumours in dogs and sarcoma in Lewis rats. Presented at the 28th Brno Oncology Conference, 2004. Abstract 168.
Rambow F, Piton G, Bouet S, Leplat JJ, Baulande S, Marrau A, Stam M, Horak V, Vincent-Naulleau S. Gene expression signature for spontaneous cancer regression in melanoma pigs. Neoplasia. 2008. July;10(7):714–722. PMID: 18592010 PMCID: PMC2435007. PubMed PMC
Vincent-Naulleau S, Le Chalony C, Leplat JJ, Bouet S, Bailly C, Spatz A, Vielh P, Avril MF, Tricaud Y, Gruand J, et al. Clinical and histopathological characterization of cutaneous melanomas in the melanoblastoma-bearing Libechov minipig model. Pigment Cell Res. 2004. February;17(1):24–35. PMID: 14717842. PubMed
Horak V, Moravkova A, Strnadel J, Hradecky J, Usvald D, Vannucci L. Devitalization as a special surgical tumour treatment inducing anti-cancer response – an experimental study in two animal models. Abstracts – 6th Annual Meeting CIMT, 15.-16.5 2008, Mainz, Germany, P65
Vanden Berghe T, Linkermann A, Jouan-Lanhouet S, Walczak H, Vandenabeele P. Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat Rev Mol Cell Biol. 2014. February;15(2):135–147. PMID: 24452471 doi:10.1038/nrm3737. PubMed DOI
Belizário J, Vieira-Cordeiro L, Enns S. Necroptotic cell death signaling and execution pathway: lessons from knockout mice. Mediators Inflamm. 2015;2015:128076 PMID: 26491219 PMCID: PMC4600508 doi:10.1155/2015/128076. PubMed DOI PMC
Hernandez C, Huebener P, Schwabe RF. Damage-associated molecular patterns in cancer: a double-edged sword. Oncogene. 2016. November 17;35(46):5931–5941. PMID: 27086930 PMCID: PMC5119456 doi:10.1038/onc.2016.104. PubMed DOI PMC
Condamine T, Ramachandran I, Youn JI, Gabrilovich DI. Regulation of tumor metastasis by myeloid-derived suppressor cells. Annu Rev Med. 2015;66:97–110. PMID: 25341012 PMCID: PMC4324727 doi:10.1146/annurev-med-051013-052304. PubMed DOI PMC
Weiser MR, Williams JP, Moore FD Jr, Kobzik L, Ma M, Hechtman HB, Carroll MC. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J Exp Med. 1996. May 1;183(5):2343–2348. PubMed PMID: 8642343; PubMed Central PMCID: PMC2192547. PubMed PMC
Sheu EG, Wakatsuki K, Younan G, Oakes SM, Moore FD. Ischemic injury inhibits cancer metastasis by modulation of host adaptive immunity. J Am Coll Surgeons. 2011;213(3)S137.
Postow MA, Callahan MK, Barker CA, Yamada Y, Yuan J, Kitano S, Mu Z, Rasalan T, Adamow M, Ritter E, et al. Immunologic correlates of the abscopal effect in a patient with melanoma. N Engl J Med. 2012. March 8;366(10):925–931. PubMed PMID: 22397654; PubMed Central PMCID: PMC3345206. doi:10.1056/NEJMoa1112824. PubMed DOI PMC
Reed CM, Cresce ND, Mauldin IS, Slingluff CL Jr, Olson WC. Vaccination with melanoma helper peptides induces antibody responses associated with improved overall survival. Clin Cancer Res. 2015. September 1;21(17):3879–3887. Epub 2015 May 12 PubMed PMID: 25967144; PubMed Central PMCID: PMC4558239 doi:10.1158/1078-0432.CCR-15-0233. PubMed DOI PMC
Hu ZI, McArthur HL, Ho AY. The abscopal effect of radiation therapy: what is it and how can we use it in breast cancer? Curr Breast Cancer Rep. 2017;9(1):45–51. PMID: 28344743 doi:10.1007/s12609-017-0234-y. PubMed DOI PMC
Andtbacka RH, Kaufman HL, Collichio F, Amatruda T, Senzer N, Chesney J, Delman KA, Spitler LE, Puzanov I, Agarwala SS, et al. Talimogene laherparepvec improves durable response rate in patients with advanced melanoma. J Clin Oncol. 2015. September 1;33(25):2780–2788. PMID: 26014293 doi:10.1200/JCO.2014.58.3377. PubMed DOI